Detalhe da pesquisa
1.
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.
Cell
; 170(5): 927-938.e20, 2017 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28841418
2.
A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2).
Gynecol Oncol
; 182: 75-81, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262242
3.
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.
Cancer Immunol Immunother
; 72(1): 183-191, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35779095
4.
Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study.
Gynecol Oncol
; 169: 64-69, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512912
5.
TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition.
Mod Pathol
; 35(1): 117-127, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34561551
6.
Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series.
Int J Gynecol Cancer
; 32(8): 1017-1024, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545291
7.
Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases.
Mod Pathol
; 34(8): 1570-1587, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33772212
8.
Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy.
Gynecol Oncol
; 158(2): 303-308, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32507515
9.
A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer.
Gynecol Oncol
; 157(1): 214-221, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959492
10.
Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study.
Int J Gynecol Cancer
; 30(12): 1915-1921, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106271
11.
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.
Int J Gynecol Cancer
; 30(10): 1554-1561, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32522770
12.
Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer.
Gynecol Oncol
; 155(1): 51-57, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31421916
13.
Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status.
Gynecol Oncol
; 154(1): 144-149, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31113680
14.
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade.
Gynecol Oncol
; 152(2): 251-258, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30470581
15.
A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer.
Future Oncol
; 14(2): 123-136, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29098867
16.
A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer.
Int J Gynecol Cancer
; 28(6): 1176-1182, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29757876
17.
Genetic predisposition to bevacizumab-induced hypertension.
Gynecol Oncol
; 147(3): 621-625, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28969913
18.
Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine.
Gynecol Oncol
; 147(2): 402-407, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843653
19.
A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
Int J Gynecol Cancer
; 26(2): 255-60, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26745694
20.
Ovarian clear cell carcinoma, outcomes by stage: the MSK experience.
Gynecol Oncol
; 139(2): 236-41, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26404183